| http://www.w3.org/ns/prov#value | - says patients considering the treatment should discuss the pros and cons with a neurologist or other doctor familiar with MS and CCSVI.In a release, the FDA says it has learned of adverse events experienced by people who have undergone the treatment, including death, stroke, detachment and migration of stents that are sometimes used to open the veins, damage to the treated vein, blood clots, cran
|
